ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Recruiting

Back to Cognitive Dysfunction trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Rutgers - Institute for Health, New Brunswick, New Jersey

Key details

Phase

Safety & dosing

Sponsor

Michal Schnaider Beeri, Ph.D.

Enrollment target

~20 participants

Started

January 2025

Primary completion

April 2027

Age range

60 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov

ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults — Stella